Question 1

How many shares of CLDX does BNP PARIBAS FINANCIAL MARKETS own?

Accepted Answer

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS holds 31,191 shares of CLDX (Celldex Therapeutics, Inc.).

Question 2

What is BNP PARIBAS FINANCIAL MARKETS's CLDX position worth?

Accepted Answer

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS's CLDX position is worth $1.2M.

Question 3

Is BNP PARIBAS FINANCIAL MARKETS buying or selling CLDX?

Accepted Answer

In 2026-Q2, BNP PARIBAS FINANCIAL MARKETS decreased their CLDX position (-82.3% change in shares).

Question 4

When did BNP PARIBAS FINANCIAL MARKETS first buy CLDX?

Accepted Answer

Based on available 13F filings, BNP PARIBAS FINANCIAL MARKETS first reported a position in CLDX in 2024-Q3. They have held the position across 31 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	31,191	-82.3%	$1.2M	0.0%	$37.21	0
2026-Q1	Decreased	175,788	-23.8%	$5.6M	0.0%	$28.94	0
2025-Q4	Increased	230,662	+72.3%	$6.3M	0.0%	$26.43	41
2025-Q3	Decreased	133,883	-36.6%	$3.5M	0.0%	$26.19	0
2025-Q2	Increased	211,260	+100.9%	$4.3M	0.0%	$20.29	43
2025-Q1	Increased	105,140	+67.9%	$1.9M	0.0%	$19.93	38
2024-Q4	Increased	62,631	+122.3%	$1.6M	0.0%	$25.12	41
2024-Q3	Increased	28,181	+293.1%	$957,872	0.0%	$33.20	40